Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Interview: MindMed’s Robert Barrow Shares Insights on Study to show Key Differences Between LSD and Psilocybin

PharmaShots Interview: MindMed’s Robert Barrow Shares Insights on Study to show Key Differences Between LSD and Psilocybin

  • May 30, 2022
IASO Biotherapeutics Reports the NMPA’s Acceptance of IND Application for Equecabtagene Autoleucel to Treat Neuromyelitis Optica Spectrum Disorder

IASO Biotherapeutics Reports the NMPA’s Acceptance of IND Application for Equecabtagene Autoleucel to Treat Neuromyelitis Optica S...

  • May 30, 2022
AstraZeneca Reports the First Patients Dosing of Saphnelo (anifrolumab) in the P-III (IRIS) Trial for the Treatment of Lupus Nephritis

AstraZeneca Reports the First Patients Dosing of Saphnelo (anifrolumab) in the P-III (IRIS) Trial for the Treatment of Lupus Nephr...

  • May 30, 2022
PharmEnable Entered into a Multi-Target Collaboration with Denali to Discover Therapies for the Treatment of Neurodegenerative Disease

PharmEnable Entered into a Multi-Target Collaboration with Denali to Discover Therapies for the Treatment of Neurodegenerative Dis...

  • May 30, 2022
Novartis’ Kymriah (tisagenlecleucel) CAR-T Cell Therapy Receives the US FDA’s Approval for the Treatment of Follicular Lymphoma

Novartis’ Kymriah (tisagenlecleucel) CAR-T Cell Therapy Receives the US FDA’s Approval for the Treatment of Follicular Lymphoma

  • May 30, 2022
Inovio Presents Results of INO-5401 + INO-9012 & Libtayo (cemiplimab) for the Treatment of Glioblastoma at ASCO 2022

Inovio Presents Results of INO-5401 + INO-9012 & Libtayo (cemiplimab) for the Treatment of Glioblastoma at ASCO 2022

  • May 30, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.